BlackRock
IPSC icon

BlackRock’s Century Therapeutics IPSC Stock Holding History

BlackRock’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Buy
1,524,422
+922,556
+153% +$1.94M ﹤0.01% 3970
2025
Q4 		$599K Buy
601,866
+2,210
+0.4% +$1.35K ﹤0.01% 4442
2025
Q3 		$299K Sell
599,656
-325,027
-35% -$175K ﹤0.01% 4594
2025
Q2 		$517K Sell
924,683
-2,093,832
-69% -$1.12M ﹤0.01% 4433
2025
Q1 		$1.44M Sell
3,018,515
-18,733
-0.6% -$14.1K ﹤0.01% 4091
2024
Q4 		$3.07M Buy
3,037,248
+47,328
+2% +$64.4K ﹤0.01% 3908
2024
Q3 		$5.11M Buy
2,989,920
+94,307
+3% +$185K ﹤0.01% 3687
2024
Q2 		$7.38M Buy
2,895,613
+1,397,432
+93% +$4.42M ﹤0.01% 3537
2024
Q1 		$6.26M Sell
1,498,181
-20,815
-1% -$88.1K ﹤0.01% 3584
2023
Q4 		$5.04M Sell
1,518,996
-76,098
-5% -$139K ﹤0.01% 3690
2023
Q3 		$3.19M Sell
1,595,094
-20,080
-1% -$53.4K ﹤0.01% 3844
2023
Q2 		$5.1M Buy
1,615,174
+203,725
+14% +$657K ﹤0.01% 3724
2023
Q1 		$4.9M Sell
1,411,449
-42,296
-3% -$186K ﹤0.01% 3646
2022
Q4 		$7.46M Buy
1,453,745
+44,582
+3% +$421K ﹤0.01% 3531
2022
Q3 		$13.9M Buy
1,409,163
+102,978
+8% +$1.08M ﹤0.01% 3242
2022
Q2 		$11M Buy
1,306,185
+277,928
+27% +$2.73M ﹤0.01% 3460
2022
Q1 		$12.9M Buy
1,028,257
+200,834
+24% +$2.66M ﹤0.01% 3447
2021
Q4 		$13.1M Buy
827,423
+178,767
+28% +$3.36M ﹤0.01% 3511
2021
Q3 		$16.3M Buy
+648,656
New +$17.6M ﹤0.01% 3417

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock's IPSC Position: Q1 2026 in Review

BlackRock increased its Century Therapeutics (IPSC) stake by 153% in Q1 2026, buying an estimated $1.94M and bringing the position to 1,524,422 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3970.

BlackRock first reported a position in IPSC in Q3 2021 and has held it in 19 quarters since. The position peaked at $16.3M in Q3 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • BlackRock held 1,524,422 shares of Century Therapeutics worth $3.45M as of Q1 2026.
  • BlackRock bought 922,556 Century Therapeutics shares in Q1 2026, an estimated $1.94M.
  • Century Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3970 holding.
  • BlackRock first reported a position in Century Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • BlackRock's Century Therapeutics position peaked at $16.3M in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.